$13.38
3.2131.56%
Last update: Nov 9, 5:40 PM
Iambic Therapeutics Inc
IAMNASDAQ
The average analyst price target for Iambic Therapeutics is $24.67, 79.6% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $22 to $30. The latest change came on Nov 9, 2026, when JP Morgan initiated coverage of Iambic Therapeutics with an Overweight rating and a $22 price target.
Price Target Range — 1 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
